Kornitzer Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Buy |
|
|||||
|
2025
Q2 | $7.55M | Buy |
|
|||||
|
2025
Q1 | $540K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.9M | Hold |
|
|||||
|
2023
Q2 | $4.18M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $257K | Hold |
|
|||||
|
2022
Q3 | $216K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $549K | Hold |
|
|||||
|
2021
Q4 | $570K | Hold |
|
|||||
|
2021
Q3 | $634K | Hold |
|
|||||
|
2021
Q2 | $570K | Sell |
|
|||||
|
2021
Q1 | $813K | Sell |
|
|||||
|
2020
Q4 | $8.07M | Sell |
|
|||||
|
2020
Q3 | $13.8M | Buy |
|
|||||
|
2020
Q2 | $9.08M | Buy |
|
|||||
|
2020
Q1 | $731K | Hold |
|
|||||
|
2019
Q4 | $774K | Sell |
|
|||||
|
2019
Q3 | $693K | Sell |
|
|||||
|
2019
Q2 | $700K | Hold |
|
|||||
|
2019
Q1 | $902K | Hold |
|
|||||
|
2018
Q4 | $704K | Sell |
|
|||||
|
2018
Q3 | $2.24M | Sell |
|
|||||
|
2018
Q2 | $24M | Buy |
|
|||||
|
2018
Q1 | $25.5M | Buy |
|
|||||
|
2017
Q4 | $26.9M | Buy |
|
|||||
|
2017
Q3 | $19.1M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $6.21M | Sell |
|
|||||
|
2016
Q2 | $9.9M | Buy |
|
|||||
|
2016
Q1 | $6.92M | Buy |
|
|||||
|
2015
Q4 | $8.58M | Buy |
|
|||||
|
2015
Q3 | $4.5M | Buy |
|
|||||
|
2015
Q2 | $4.98M | Sell |
|
|||||
|
2015
Q1 | $4.35M | Sell |
|
|||||
|
2014
Q4 | $4.08M | Sell |
|
|||||
|
2014
Q3 | $4.68M | Hold |
|
|||||
|
2014
Q2 | $3.79M | Buy |
|
|||||
|
2014
Q1 | $3.49M | Buy |
|